SBC Medical Group (NASDAQ:SBC) Releases Earnings Results, Misses Expectations By $0.02 EPS

Posted by Brian Himes on Aug 13th, 2026

SBC Medical Group (NASDAQ:SBC – Get Free Report) announced its earnings results on Thursday. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02), FiscalAI reports. SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%.The business had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million.

Here are the key takeaways from SBC Medical Group’s conference call:

Positive Sentiment: SBC reported strong second-quarter results, with revenue up 13% to $49 million, adjusted EBITDA up 32% to $20 million, and a 41% margin. Clinic locations increased to 287, visits rose 10%, and average spend per visit increased 9%.
Positive Sentiment: Management said domestic aesthetic medicine has re-accelerated after marketing, pricing, and treatment reforms, with same-clinic revenue up 6% and first-half transaction value up 19%. It expects a more favorable competitive environment as the pace of new clinic openings slows.
Positive Sentiment: AI is being deployed across customer service, marketing, call-center operations, site selection, and employee training, with management targeting higher clinic revenue and greater operating efficiency. Planned service-fee increases are expected to add roughly JPY 15 million annually, with most of the contribution flowing to profit.
Positive Sentiment: The company is broadening beyond aesthetics through non-aesthetic healthcare, international expansion, and new longevity offerings. It is targeting 1,000 clinics by 2035, while pursuing asset-light expansion in Southeast Asia and further growth with OrangeTwist in the U.S.
Negative Sentiment: A weaker Japanese yen remains a headwind because most operations are yen-denominated, while competition in Japan has recently been intense. SG&A also increased, although management attributed much of the rise to one-time costs related to the secondary offering.

SBC Medical Group Stock Performance

NASDAQ SBC traded down $0.14 during trading hours on Thursday, hitting $3.06. The company had a trading volume of 225,017 shares, compared to its average volume of 88,658. The company has a quick ratio of 3.78, a current ratio of 3.82 and a debt-to-equity ratio of 0.12. SBC Medical Group has a fifty-two week low of $2.78 and a fifty-two week high of $5.07. The business has a fifty day simple moving average of $3.07 and a 200-day simple moving average of $3.57. The firm has a market cap of $313.38 million, a P/E ratio of 7.84 and a beta of 0.59.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Weiss Ratings lowered SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of SBC Medical Group to a “hold” rating in a research note on Saturday, May 9th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, SBC Medical Group has a consensus rating of “Hold” and a consensus target price of $8.50.

View Our Latest Stock Report on SBC

Hedge Funds Weigh In On SBC Medical Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Goldman Sachs Group Inc. bought a new position in SBC Medical Group in the 4th quarter worth approximately $49,000. Russell Investments Group Ltd. boosted its position in SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after acquiring an additional 8,771 shares during the period. Nuveen LLC bought a new position in shares of SBC Medical Group in the fourth quarter worth $53,000. Wells Fargo & Company MN grew its stake in shares of SBC Medical Group by 195.1% in the fourth quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock worth $54,000 after purchasing an additional 8,348 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of SBC Medical Group during the second quarter valued at $64,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

About SBC Medical Group

(Get Free Report)

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.